R Badaro Selected Research

Antimony

8/2001

Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal Leishmaniasis refractory to antimony: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Badaro Research Topics

Disease

2	Leishmaniasis 08/2001 - 01/2001
2	Tuberculosis (Tuberculoses) 07/2001 - 09/2000
2	Infections 07/2001 - 09/2000
2	Neoplasms (Cancer) 06/2001 - 03/2000
1	Erythema 08/2001
1	Breast Neoplasms (Breast Cancer) 06/2001
1	Cutaneous Leishmaniasis 01/2001
1	Opportunistic Infections (Opportunistic Infection) 11/2000
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2000
1	Chagas Disease (American Trypanosomiasis) 01/2000

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 08/2001 - 09/2000
2	VaccinesIBA 08/2001 - 01/2001
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2001 - 11/2000
1	CytokinesIBA 08/2001
1	AntimonyIBA 08/2001
1	Vaccine AdjuvantsIBA 08/2001
1	Immunodominant EpitopesIBA 07/2001
1	SiliconIBA 06/2001
1	DNA (Deoxyribonucleic Acid)IBA 06/2001
1	EnzymesIBA 01/2001
1	sargramostim (Leukine)FDA Link 11/2000
1	NucleosidesIBA 11/2000
1	Complement System Proteins (Complement)IBA 09/2000
1	Recombinant ProteinsIBA 01/2000
1	Peptides (Polypeptides)IBA 01/2000
1	AntibodiesIBA 01/2000

Therapy/Procedure

2	Therapeutics 11/2000 - 03/2000
1	Immunotherapy 08/2001
1	Injections 08/2001